Scheduled Commit

data/retrieval_individual-2cea24b1-39e9-480a-ba22-c617ea05c1fe.jsonl

@@ -74,3 +74,5 @@
 {"tstamp": 1724050329.5374, "task_type": "retrieval", "type": "chat", "model": "BM25", "gen_params": {}, "start": 1724050327.223, "finish": 1724050329.5374, "ip": "", "conv_id": "6a07cb70aa93442aa70bcf0c4a789ed7", "model_name": "BM25", "prompt": "Which test was devised to determine whether robots can think?", "output": [["Which test was devised to determine whether robots can think?", "Artificial intelligence\n\nIn the late teens and early 2020s, AGI companies began to deliver programs that created enormous interest. In 2015, AlphaGo, developed by DeepMind, beat the world champion Go player. The program was taught only the rules of the game and developed strategy by itself. GPT-3 is a large language model that was released in 2020 by OpenAI and is capable of generating high-quality human-like text. These programs, and others, inspired an aggressive AI boom, where large companies began investing billions in AI research. According to AI Impacts, about $50 billion annually was invested in \"AI\" around 2022 in the U.S. alone and about 20% of the new U.S. Computer Science PhD graduates have specialized in \"AI\".\nAbout 800,000 \"AI\"-related U.S. job openings existed in 2022.\nPhilosophy\nDefining artificial intelligence\nAlan Turing wrote in 1950 \"I propose to consider the question 'can machines think'?\" He advised changing the question from whether a machine \"thinks\", to \"whether or not it is possible for machinery to show intelligent behaviour\". He devised the Turing test, which measures the ability of a machine to simulate human conversation. Since we can only observe the behavior of the machine, it does not matter if it is \"actually\" thinking or literally has a \"mind\". Turing notes that we can not determine these things about other people but \"it is usual to have a polite convention that everyone thinks.\""]], "corpus": "wikipedia"}
 {"tstamp": 1724051324.0339, "task_type": "retrieval", "type": "chat", "model": "Alibaba-NLP/gte-Qwen2-7B-instruct", "gen_params": {}, "start": 1724051323.4192, "finish": 1724051324.0339, "ip": "", "conv_id": "3ff95f6b91be4b3a9cd28c646ffb7820", "model_name": "Alibaba-NLP/gte-Qwen2-7B-instruct", "prompt": "肺癌患者应该注意什么？", "output": [["肺癌患者应该注意什么？", "Lung cancer\n\nPeople whose NSCLC is not targetable by current molecular therapies instead can be treated with combination chemotherapy plus immune checkpoint inhibitors, which prevent cancer cells from inactivating immune T cells. The chemotherapeutic agent of choice depends on the NSCLC subtype: cisplatin plus gemcitabine for squamous cell carcinoma, cisplatin plus pemetrexed for non-squamous cell carcinoma. Immune checkpoint inhibitors are most effective against tumors that express the protein PD-L1, but are sometimes effective in those that do not. Treatment with pembrolizumab, atezolizumab, or combination nivolumab plus ipilimumab are all superior to chemotherapy alone against tumors expressing PD-L1. Those who relapse on the above are treated with second-line chemotherapeutics docetaxel and ramucirumab.\nPalliative care\nIntegrating palliative care (medical care focused on improving symptoms and lessening discomfort) into lung cancer treatment from the time of diagnosis improves the survival time and quality of life of those with lung cancer. Particularly common symptoms of lung cancer are shortness of breath and pain. Supplemental oxygen, improved airflow, re-orienting an affected person in bed, and low-dose morphine can all improve shortness of breath. In around 20 to 30% of those with lung cancer – particularly those with late-stage disease – growth of the tumor can narrow or block the airway, causing coughing and difficulty breathing. Obstructing tumors can be surgically removed where possible, though typically those with airway obstruction are not well enough for surgery. In such cases the American College of Chest Physicians recommends opening the airway by inserting a stent, attempting to shrink the tumor with localized radiation (brachytherapy), or physically removing the blocking tissue by bronchoscopy, sometimes aided by thermal or laser ablation. Other causes of lung cancer-associated shortness of breath can be treated directly, such as antibiotics for a lung infection, diuretics for pulmonary edema, benzodiazepines for anxiety, and steroids for airway obstruction."]], "corpus": "wikipedia"}
 {"tstamp": 1724051324.0339, "task_type": "retrieval", "type": "chat", "model": "text-embedding-3-large", "gen_params": {}, "start": 1724051323.4192, "finish": 1724051324.0339, "ip": "", "conv_id": "1fc867de7ad04bb5b59275bfae1ce939", "model_name": "text-embedding-3-large", "prompt": "肺癌患者应该注意什么？", "output": [["肺癌患者应该注意什么？", "Lung cancer\n\nmonitoring population-level tobacco use and the effectiveness of tobacco control policies.\nPolicies implementing each intervention are associated with decreases in tobacco smoking prevalence. The more policies implemented, the greater the reduction. Reducing access to tobacco for adolescents is particularly effective at decreasing uptake of habitual smoking, and adolescent demand for tobacco products is particularly sensitive to increases in cost.\nDiet and lifestyle\nSeveral foods and dietary supplements have been associated with lung cancer risk. High consumption of some animal products – red meat (but not other meats or fish), saturated fats, as well as nitrosamines and nitrites (found in salted and smoked meats) – is associated with an increased risk of developing lung cancer. In contrast, high consumption of fruits and vegetables is associated with a reduced risk of lung cancer, particularly consumption of cruciferous vegetables and raw fruits and vegetables. Based on the beneficial effects of fruits and vegetables, supplementation of several individual vitamins have been studied. Supplementation with vitamin A or beta-carotene had no effect on lung cancer, and instead slightly increased mortality. Dietary supplementation with vitamin E or retinoids similarly had no effect. Consumption of polyunsaturated fats, tea, alcoholic beverages, and coffee are all associated with reduced risk of developing lung cancer."]], "corpus": "wikipedia"}
+{"tstamp": 1724051374.2782, "task_type": "retrieval", "type": "chat", "model": "Alibaba-NLP/gte-Qwen2-7B-instruct", "gen_params": {}, "start": 1724051373.8012, "finish": 1724051374.2782, "ip": "", "conv_id": "75715c9b4af24b7990b5747cf3e49b82", "model_name": "Alibaba-NLP/gte-Qwen2-7B-instruct", "prompt": "肺癌患者应该注意什么？请用中文回答", "output": [["肺癌患者应该注意什么？请用中文回答", "Lung cancer\n\nPeople whose NSCLC is not targetable by current molecular therapies instead can be treated with combination chemotherapy plus immune checkpoint inhibitors, which prevent cancer cells from inactivating immune T cells. The chemotherapeutic agent of choice depends on the NSCLC subtype: cisplatin plus gemcitabine for squamous cell carcinoma, cisplatin plus pemetrexed for non-squamous cell carcinoma. Immune checkpoint inhibitors are most effective against tumors that express the protein PD-L1, but are sometimes effective in those that do not. Treatment with pembrolizumab, atezolizumab, or combination nivolumab plus ipilimumab are all superior to chemotherapy alone against tumors expressing PD-L1. Those who relapse on the above are treated with second-line chemotherapeutics docetaxel and ramucirumab.\nPalliative care\nIntegrating palliative care (medical care focused on improving symptoms and lessening discomfort) into lung cancer treatment from the time of diagnosis improves the survival time and quality of life of those with lung cancer. Particularly common symptoms of lung cancer are shortness of breath and pain. Supplemental oxygen, improved airflow, re-orienting an affected person in bed, and low-dose morphine can all improve shortness of breath. In around 20 to 30% of those with lung cancer – particularly those with late-stage disease – growth of the tumor can narrow or block the airway, causing coughing and difficulty breathing. Obstructing tumors can be surgically removed where possible, though typically those with airway obstruction are not well enough for surgery. In such cases the American College of Chest Physicians recommends opening the airway by inserting a stent, attempting to shrink the tumor with localized radiation (brachytherapy), or physically removing the blocking tissue by bronchoscopy, sometimes aided by thermal or laser ablation. Other causes of lung cancer-associated shortness of breath can be treated directly, such as antibiotics for a lung infection, diuretics for pulmonary edema, benzodiazepines for anxiety, and steroids for airway obstruction."]], "corpus": "wikipedia"}
+{"tstamp": 1724051374.2782, "task_type": "retrieval", "type": "chat", "model": "text-embedding-3-large", "gen_params": {}, "start": 1724051373.8012, "finish": 1724051374.2782, "ip": "", "conv_id": "2be9964542b749ff944adc83a3b6455e", "model_name": "text-embedding-3-large", "prompt": "肺癌患者应该注意什么？请用中文回答", "output": [["肺癌患者应该注意什么？请用中文回答", "Lung cancer\n\nPeople whose NSCLC is not targetable by current molecular therapies instead can be treated with combination chemotherapy plus immune checkpoint inhibitors, which prevent cancer cells from inactivating immune T cells. The chemotherapeutic agent of choice depends on the NSCLC subtype: cisplatin plus gemcitabine for squamous cell carcinoma, cisplatin plus pemetrexed for non-squamous cell carcinoma. Immune checkpoint inhibitors are most effective against tumors that express the protein PD-L1, but are sometimes effective in those that do not. Treatment with pembrolizumab, atezolizumab, or combination nivolumab plus ipilimumab are all superior to chemotherapy alone against tumors expressing PD-L1. Those who relapse on the above are treated with second-line chemotherapeutics docetaxel and ramucirumab.\nPalliative care\nIntegrating palliative care (medical care focused on improving symptoms and lessening discomfort) into lung cancer treatment from the time of diagnosis improves the survival time and quality of life of those with lung cancer. Particularly common symptoms of lung cancer are shortness of breath and pain. Supplemental oxygen, improved airflow, re-orienting an affected person in bed, and low-dose morphine can all improve shortness of breath. In around 20 to 30% of those with lung cancer – particularly those with late-stage disease – growth of the tumor can narrow or block the airway, causing coughing and difficulty breathing. Obstructing tumors can be surgically removed where possible, though typically those with airway obstruction are not well enough for surgery. In such cases the American College of Chest Physicians recommends opening the airway by inserting a stent, attempting to shrink the tumor with localized radiation (brachytherapy), or physically removing the blocking tissue by bronchoscopy, sometimes aided by thermal or laser ablation. Other causes of lung cancer-associated shortness of breath can be treated directly, such as antibiotics for a lung infection, diuretics for pulmonary edema, benzodiazepines for anxiety, and steroids for airway obstruction."]], "corpus": "wikipedia"}